Superior and effective microbiome therapeutics
About us
CHAIN develops oral vaccines and immuno-therapies targeting the lower gastrointestinal tract with several therapeutic candidates in pre-clinical development.
Platform
CHAIN’s Clostridium Assisted Drug Development (CADD™) platform is centred on the use of a specific Clostridium bacterial strain and precision engineering biology is used to produce and deliver specific therapeutic payloads to the lower gastrointestinal (GI) tract.